SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG) - Specifications

Visit our webpage for more information on SARS-CoV-2, its mutations & variants and our corresponding products.

Are you interested in your other antigen peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT’s SARS-CoV-2 Antigen Peptides
Individual antigen peptides are derived from information on the human immune response towards SARS-virus, which is very similar to SARS-CoV-2. Sequences which are identical (28 peptides) or similar (13 peptides with one mutation, 7 with two and one with three) to experimentally confirmed SARS-epitopes are made available through our shop. These peptides can be used for antigen specific T-cell stimulation, T-cell assays or T-cell expansion. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- ISO 9001:2015 certified; audits welcome!
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!